Surinder K. Chander

1.9k total citations
38 papers, 1.7k citations indexed

About

Surinder K. Chander is a scholar working on Genetics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Surinder K. Chander has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 20 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Surinder K. Chander's work include Estrogen and related hormone effects (31 papers), Steroid Chemistry and Biochemistry (8 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Surinder K. Chander is often cited by papers focused on Estrogen and related hormone effects (31 papers), Steroid Chemistry and Biochemistry (8 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Surinder K. Chander collaborates with scholars based in United Kingdom, United States and Italy. Surinder K. Chander's co-authors include Michael Reed, R. Charles Coombes, Atul Purohit, Barry V. L. Potter, L. W. Lawrence Woo, Mathew P. Leese, B. V. L. POTTER, A. Purohit, Lise Binderup and Kay W. Colston and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Surinder K. Chander

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Surinder K. Chander United Kingdom	23	933	853	325	306	278	38	1.7k
Martin R. Schneider Germany	21	690 0.7×	535 0.6×	299 0.9×	510 1.7×	57 0.2×	83	1.5k
Simon P. Newman United Kingdom	23	647 0.7×	740 0.9×	391 1.2×	356 1.2×	41 0.1×	32	1.4k
Brian J. Long United States	28	1.2k 1.2×	911 1.1×	94 0.3×	779 2.5×	94 0.3×	56	2.1k
Chihuei Wang Taiwan	21	453 0.5×	1.0k 1.2×	186 0.6×	244 0.8×	59 0.2×	43	1.8k
Debra A. Tonetti United States	26	561 0.6×	935 1.1×	106 0.3×	662 2.2×	111 0.4×	57	1.7k
Rosemary E. Hall Australia	17	843 0.9×	701 0.8×	56 0.2×	531 1.7×	85 0.3×	18	1.5k
Mathew P. Leese United Kingdom	26	612 0.7×	994 1.2×	898 2.8×	280 0.9×	46 0.2×	53	1.8k
Beatrice Darimont United States	21	1.3k 1.4×	1.9k 2.2×	83 0.3×	499 1.6×	55 0.2×	30	3.0k
Allen Lovey United States	12	904 1.0×	2.1k 2.5×	539 1.7×	486 1.6×	93 0.3×	20	2.9k
Gordon Alton United States	18	293 0.3×	1.8k 2.1×	390 1.2×	739 2.4×	264 0.9×	42	2.8k

Countries citing papers authored by Surinder K. Chander

Since Specialization

Citations

This map shows the geographic impact of Surinder K. Chander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surinder K. Chander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surinder K. Chander more than expected).

Fields of papers citing papers by Surinder K. Chander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surinder K. Chander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surinder K. Chander. The network helps show where Surinder K. Chander may publish in the future.

Co-authorship network of co-authors of Surinder K. Chander

This figure shows the co-authorship network connecting the top 25 collaborators of Surinder K. Chander. A scholar is included among the top collaborators of Surinder K. Chander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surinder K. Chander. Surinder K. Chander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wood, Paul M., L. W. Lawrence Woo, Jean‐Robert Labrosse, et al.. (2010). Bicyclic Derivatives of the Potent Dual Aromatase–Steroid Sulfatase Inhibitor 2‐Bromo‐4‐{[(4‐cyanophenyl)(4H‐1,2,4‐triazol‐4‐yl)amino]methyl}phenylsulfamate: Synthesis, SAR, Crystal Structure, and in vitro and in vivo Activities. ChemMedChem. 5(9). 1577–1593. 20 indexed citations

Woo, L. W. Lawrence, Delphine S. Fischer, Paul Foster, et al.. (2008). Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography. Molecular Cancer Therapeutics. 7(8). 2435–2444. 35 indexed citations

Foster, Paul, Surinder K. Chander, Stephen T. Newman, et al.. (2008). The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer. British Journal of Cancer. 99(9). 1433–1441. 6 indexed citations

Day, Joanna M., Paul Foster, Helena J. Tutill, et al.. (2008). 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer. International Journal of Cancer. 122(9). 1931–1940. 100 indexed citations

Chander, Surinder K., et al.. (2007). Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity (vol 5, pg 2940, 2007). Organic & Biomolecular Chemistry. 5. 6 indexed citations

Woo, L. W. Lawrence, et al.. (2007). Dual aromatase–sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity. Organic & Biomolecular Chemistry. 5(18). 2940–2940. 51 indexed citations

Chander, Surinder K., Paul Foster, Mathew P. Leese, et al.. (2007). In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. British Journal of Cancer. 96(9). 1368–1376. 40 indexed citations

Purohit, A., Helena J. Tutill, Joanna M. Day, et al.. (2006). The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer. Molecular and Cellular Endocrinology. 248(1-2). 199–203. 22 indexed citations

Wood, Paul M., L. W. Lawrence Woo, Surinder K. Chander, et al.. (2005). A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity. The Journal of Steroid Biochemistry and Molecular Biology. 94(1-3). 123–130. 35 indexed citations

10.

Utsumi, Toshiaki, Mathew P. Leese, Surinder K. Chander, et al.. (2005). The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 94(1-3). 219–227. 29 indexed citations

11.

Ireson, Christopher R., Surinder K. Chander, A. Purohit, et al.. (2004). Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats. British Journal of Cancer. 91(7). 1399–1404. 24 indexed citations

12.

Ireson, Christopher R., Surinder K. Chander, A. Purohit, et al.. (2004). Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer. 90(4). 932–937. 113 indexed citations

13.

Ireson, Christopher R., David C. Parish, Atul Purohit, et al.. (2003). Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 337–342. 10 indexed citations

14.

Purohit, A., L. W. Lawrence Woo, Surinder K. Chander, et al.. (2003). Steroid sulphatase inhibitors for breast cancer therapy. The Journal of Steroid Biochemistry and Molecular Biology. 86(3-5). 423–432. 56 indexed citations

15.

Wang, Xiaoen, N. Willmott, Surinder K. Chander, et al.. (1997). Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clinical & Experimental Metastasis. 15(2). 184–195. 48 indexed citations

16.

Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations

17.

Smith, Janet, et al.. (1993). The effect of endocrine therapy on fibroblast growth factor-like activity in nitrosomethylurea-induced rat mammary tumours. European Journal of Cancer. 29(15). 2125–2131. 3 indexed citations

18.

Chander, Surinder K., Surinder S. Sahota, T.R. Jeffry Evans, & Yunus A. Luqmani. (1993). The biological evaluation of novel antioestrogens for the treatment of breast cancer. Critical Reviews in Oncology/Hematology. 15(3). 243–269. 11 indexed citations

19.

Skilton, Robert A., et al.. (1992). Clinical and biological significance of HSP89 alpha in human breast cancer. International Journal of Cancer. 50(3). 409–415. 97 indexed citations

20.

Chander, Surinder K., et al.. (1992). Oestrone sulphatase activity in mammary tumours and the liver of N-nitrosomethylurea treated rats. British Journal of Cancer. 65(1). 72–76. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact